Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
Mazdutide is a peptide that is research only, not approved for human use in the US.
Also known as IBI362, LY3305677
Mazdutide is a dual-hormone medicine developed from an Eli Lilly compound and advanced by Innovent. Authorization in another country does not make RUO vials sold online an approved US medicine.

Not approved for human use in the US. We list it so you can learn what it is, but we do not link to anyone selling it. Not FDA-approved and not lawfully marketed for personal use in the US. It has a separate regulatory pathway in China.
As of September 28, 2026.
Human trials have evaluated weight and metabolic outcomes, but US approval and an FDA-reviewed label do not exist.
These save with the compound when you add it to My Journal, so they’re on the printout for your visit.
Mazdutide is not approved for human use, so DiscoverMedica links to no seller.
We don’t link to sellers of research-only compounds. Products sold “for research use only” are not made for people and are not held to pharmaceutical quality standards.
Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.
A GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
A weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.
An older, daily GLP-1 injection for weight management and diabetes, now available as a generic.
A cheap, decades-old diabetes pill that some people ask about for weight and healthy aging.